000 02237cam  2200397zi 4500
0019.911403
003CaOODSP
00520230906143914
006m     o  d f      
007cr cn|||||||||
008220519t20222019onc     o    f000 0 eng d
020 |a9780660436005
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-249/2022E-PDF
24500|aReporting adverse events following immunization (AEFI) in Canada : |buser guide to completion and submission of the AEFI reports.
24610|aUser guide to completion and submission of the AEFI reports
24617|aUser guide : |bAEFI report form
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de santé publique du Canada, |c2022.
264 4|c©2019
300 |a1 online resource (36 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"Publication date: June 2022."
500 |aIssued also in French under title: Déclaration de manifestations cliniques inhabituelles (MCI) à la suite d’une immunisation au Canada : guide de l’utilisateur pour remplir et soumettre les rapports de déclaration de MCI.
520 |a"An AEFI is any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine. The adverse event may be any unfavourable or unintended sign, abnormal laboratory finding, symptom or disease"--Background, page 3.
650 0|aImmunization|xComplications|zCanada.
650 0|aVaccination|xComplications|zCanada.
650 0|aDrugs|xSide effects|xReporting|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tDéclaration de manifestations cliniques inhabituelles (MCI) à la suite d’une immunisation au Canada : |w(CaOODSP)9.911406
794 |tReporting adverse events following immunization (AEFI) in Canada : |b2023|w(CaOODSP)9.921366
795 |tReporting adverse events following immunization (AEFI) in Canada : |b2019|w(CaOODSP)9.868074
85640|qPDF|s1.14 MB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-249-2022-eng.pdf